MUCOSOL® – Medical Description

Dosage form: Hard gelatin capsules, pack of 20 capsules

Active ingredient:

• Carbocisteine: 375 mg per capsule

Pharmacologic class: Mucolytic agent.

Description:
MUCOSOL capsules contain Carbocisteine, a mucolytic medication used as adjunctive therapy in respiratory tract disorders associated with excessive, thick, or viscous mucus secretions. Carbocisteine works by modifying mucus composition and reducing mucus viscosity, helping respiratory secretions become less sticky and easier to remove by coughing. It is commonly used to improve mucus clearance in acute and chronic respiratory conditions.

Therapeutic uses:

• Productive cough associated with thick mucus
• Acute bronchitis
• Chronic bronchitis
• Chronic obstructive airway diseases associated with excessive secretions
• Respiratory tract disorders characterized by difficult-to-expectorate mucus

Mechanism of action:

• Mucolytic activity: Carbocisteine reduces the viscosity and elasticity of bronchial mucus.
• Mucoregulating effect: Helps normalize mucus composition and improve mucus transport.
• Improved mucus clearance: Facilitates expectoration and enhances airway secretion removal.

Possible adverse effects:
Common adverse reactions may include:

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Indigestion
• Headache
• Dizziness
• Skin rash or hypersensitivity reactions

Less commonly:

• Gastrointestinal bleeding
• Peptic ulcer aggravation
• Severe allergic reactions

Important precautions and warnings:

• Do not use in patients with known hypersensitivity to Carbocisteine or any formulation component.
• Use cautiously in patients with a history of peptic ulcer disease, since gastrointestinal irritation may occur.
• Patients with severe kidney or liver impairment should consult a healthcare professional before use.
• Persistent cough lasting more than several weeks may require further medical evaluation.
• Patients should maintain adequate fluid intake to support mucus clearance.

Supplemental (inactive) ingredients consideration:
Specific excipients for MUCOSOL® 375 mg capsules were not provided. However, carbocisteine capsule formulations commonly contain excipients such as gelatin capsule shell, lactose monohydrate, magnesium stearate, colloidal silica, sodium lauryl sulfate, and coloring agents. Patients with lactose intolerance, known allergies to capsule components, or sensitivities to dyes/excipients should review the package insert before use because composition can vary among manufacturers. This is based on published carbocisteine capsule formulations and may differ from the exact MUCOSOL product.

Patient Disclaimer:
This information is intended for educational purposes only and does not replace physician or pharmacist advice. Patients should use MUCOSOL exactly as prescribed or according to approved labeling. Seek medical attention if symptoms persist, worsen, or are accompanied by fever, chest pain, shortness of breath, wheezing, or coughing blood. Patients who are pregnant, breastfeeding, have gastrointestinal disease, kidney disease, liver disease, or take other medications should consult a healthcare professional before use.